Anti-i-j monoclonal antibody
Anti-i-j monoclonal antibody has been studied in 1 paper since 1984: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Oct 31, 1984: “Effects of long-term treatment of mice with anti-I-J monoclonal antibody and dialyzable leukocyte extract on immune function and lifespan”.
1 paper studies it3 findingsUpdated
None of its findings points the other way.
- 1 lab in 1 country
- Funders: Medical University of South Carolina and 2 more
- Animals1
What did studies of Anti-i-j monoclonal antibody find?
3Studies of Anti-i-j monoclonal antibody measured 3 outcomes; the most studied are lifespan (1 study), secondary antibody response (1) and T-helper cells (1).
Lifespan
upin mice1
1 study
Lifespan
upin mice1
Anti-i-j monoclonal antibody extends lifespan in mice.
“Mice treated with anti-I-J antibody survived longer than did mice of the other two groups.”
Animalsweekly treatment compared to saline and dialyzable leukocyte extract
Mechanisms of ageing and development
Secondary antibody response
upin mice1
1 study
Secondary antibody response
upin mice1
Anti-i-j monoclonal antibody increases secondary antibody response in mice.
“Both types of immunologic intervention resulted in a greater secondary antibody response than that of the saline-treated control mice.”
Animalsimmunized with avian gammaglobulin at 27 and 29 months of age
Mechanisms of ageing and development
T-helper cells
upin mice1
1 study
T-helper cells
upin mice1
Anti-i-j monoclonal antibody increases T-helper cells in mice.
“Mice treated with anti-I-J antibody had elevated T-helper cell activity.”
Animalstreated once a week for one yearspleen1 year
Mechanisms of ageing and development